A two-in-one integrated assay for analyzing circRNA-microRNA interactions

Through the two-in-one integrated assay, the high sensitivity analysis of circRNA-microRNA interaction is achieved using functionalized magnetic beads and rolling ring amplification technology, solving the problems of low sensitivity and high detection difficulty in the existing technology, and providing A convenient and efficient tool for analyzing the interaction between circRNA and miRNA.

CN113481282BActive Publication Date: 2024-11-19NANJING UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110092508.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-01-24
Publication Date
2024-11-19
Estimated Expiration
2041-01-24

AI Technical Summary

Technical Problem

Existing methods have low sensitivity when analyzing circRNA-microRNA interactions, making it difficult to achieve direct quantitative analysis, and cannot detect low-expressed circRNA and miRNA interactions. Conventional methods require targeting two RNA molecules respectively, which is time-consuming and labor-intensive.

Method used

A two-in-one integrated assay was used to separate the circRNA/miRNA complex through functionalized magnetic bead capture probes, and rolling circle amplification was performed using miRNA as primers to generate fluorescent signals, which directly reveals the mutual interaction between circRNA and miRNA. to achieve high sensitivity quantitative analysis.

Benefits of technology

This method can analyze circRNA-miRNA interactions with high sensitivity, directly revealing the interaction between circRNA and miRNA, replacing the shortcomings of traditional methods, and providing a convenient and efficient tool for understanding circRNA function and disease mechanisms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113481282B_ABST
    Figure CN113481282B_ABST
Patent Text Reader

Abstract

The present invention discloses a two-in-one integrated assay for analyzing circRNA-microRNA interactions, comprising the following steps: (1) preparing functionalized MBs: the capture probe is fixed on the surface of SA-MBs through the specific binding between biotin and streptavidin; (2) circRNA-miRNA interaction analysis. The assay method of the present invention has high sensitivity and can be used for analyzing circRNA-miRNA interactions (cmRRI), which is expected to provide a useful tool for analyzing cmRRIs in RNA dialogue systems in biomedical and clinical inventions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of gene technology, and in particular to a two-in-one integrated assay for analyzing circRNA-microRNA interactions. Background Art

[0002] RNA-RNA interactions (RRI) play an important regulatory role in various basic cellular life activities. For example, transfer RNA (tRNA) interacts with messenger RNA (mRNA) to translate genetic code; miRNA interacts with mRNA to promote its degradation; circular RNA (circRNA) interacts with miRNA by acting as a molecular sponge, which is called the sponge effect. Among them, the sponge effect is a classic model of gene regulation mediated by circRNA. Exploring the circRNA-miRNA sponge effect can not only expand the current understanding of the RNA interaction genome of the present invention, but also help to understand the biological functions of non-polyA circRNA and the signaling pathways involved in disease development. CircRNA contains a large number of miRNA response elements (MREs), which enable them to competitively bind to miRNA, resulting in downregulation of functional miRNA and upregulation of target miRNA downstream proteins. The dysregulation of these signaling pathways is closely related to a variety of human diseases, such as cancer, cardiovascular disease, neurological diseases and type 2 diabetes. However, the invention of disease-related signaling pathways mediated by circRNA-miRNA interactions (cmRRI) is still very lacking, and one of the key factors is the lack of methods that can be used to invent RNA interactions. Therefore, a convenient and efficient method for comprehensive analysis of cmRRI is crucial for understanding the functions of circRNAs and revealing the potential mechanisms of circRNA / miRNA involvement in disease development.

[0003] Regarding the interaction between circRNA and miRNA, usually, inventors will first predict the types of miRNA that circRNA may adsorb through developed circRNA molecular software, such as computational tools such as circBase and RegRNA2.0. Then, their interaction is further confirmed using classical molecular biology techniques. Electrophoretic mobility shift assay (EMSA) is the most traditional technique for detecting RNA-RNA interactions. In EMSA, circRNA-miRNA hybrids have a larger molecular weight and therefore migrate slower in electrophoresis gels than unpaired single-molecule RNA. In addition, RNA fluorescence in situ hybridization (FISH) is a powerful tool that can analyze paired RNA interactions in situ in cells by designing two probes that specifically bind to miRNA and target circRNA for in situ imaging. If the two are co-localized, it may be caused by the sponge effect. Although these classical methods have been successfully used to detect cmRRI, they are difficult to achieve direct quantitative analysis due to their low sensitivity and are not suitable for low-expression circRNAs. And FISH cannot directly verify the interaction between circRNA-miRNA because it requires the design of targeted probes for circRNA and miRNA respectively. To compensate for these shortcomings, real-time fluorescence quantitative PCR (qRT-PCR) has been used as a complementary method to quantitatively analyze the expression trends of circRNA and miRNA respectively by adding inhibitors or activators. If there are opposite expression trends between the two, it indicates that there may be a sponge effect. However, the inherent disadvantage of qRT-PCR detection of circRNA is that during the reverse transcription process, rolling circle amplification with circRNA as a template is easily generated, resulting in false positive results. The inventors have also developed a new technology LIGR-seq to capture the interactions between different RNA molecules for systematic functional analysis of ncRNAs. When two RNA molecules have matching sequences, they stick together like Velcro. Then, the paired RNA structures are removed from the cells and analyzed using the most advanced sequencing methods to accurately determine the RNAs that stick together. Although this method is more accurate, RNA sequencing is accompanied by high costs and professional sequencing institutions.

[0004] In general, current methods still encounter some shortcomings in practical applications: (1) usually two related RNA molecules (circRNA and miRNA) are targeted separately to define their interaction; (2) the interaction between low-expressed circRNA and miRNA cannot be detected; (3) the detection procedure is usually time-consuming and laborious.

[0005] In part of the work, in response to these problems, the present invention proposes a biosensing strategy to directly reveal cmRRI, rather than detecting individual signal molecules individually by analyzing paired RNA complexes. In the strategy of the present invention, based on the nature of circRNA as a miRNA sponge, only when the upstream circRNA and downstream miRNA coexist in the form of an interactive complex will further reactions be triggered and output signals are finally given. Since the assay is simple, sensitive, and easy to operate, it may have practical application prospects in revealing new cmRRIs, and it is hoped that it can provide a reliable tool for the invention of cmRRI-related diseases.

[0006] Currently, there is a lack of a two-in-one integrated assay with high sensitivity for analyzing circRNA-microRNA interactions. Summary of the invention

[0007] In view of the deficiencies of the prior art, the present invention provides a two-in-one integrated assay with high sensitivity for analyzing circRNA-microRNA interactions.

[0008] In order to solve the problems of the prior art, the present invention provides the following technical solutions: A two-in-one integrated assay for analyzing circRNA-microRNA interactions of the present invention comprises the following steps: (1) preparing functionalized magnetic beads (MBs): the capture probes are immobilized on the surface of SA-MBs through the specific binding between biotin and streptavidin;

[0009] (2) circRNA-miRNA interaction analysis: After the functionalized MB separated the circRNA / miRNA complex, the rolling circle amplification (RCA) product using miRNA as primer opened the self-quenching probe to generate a fluorescent signal.

[0010] Further, in step (1), 100 μL of 10 mg / mL SA-MB was washed twice with 1 mL of washing buffer and then resuspended in 500 μL of biotin-streptavidin binding buffer.

[0011] Further, in step (1), Step 2, 2 μL of 100 μM biotinylated capture probe was added to the SA-MBs dispersion, and the mixture was then incubated on a thermomixer at 37° C. for 30 minutes.

[0012] Furthermore, in step (1), after washing three times with 1 mL of washing buffer to remove excess free probes in Step 3, the capture probe MBs were resuspended in 100 μL of hybridization buffer for subsequent experiments, and the number of probes bound to the MBs was calculated as: (concentration before reaction − concentration after reaction) × volume of reaction solution.

[0013] Further, in step (2), step 1 mixed different concentrations of circRNA (SEQ ID NO: 2), 1 μM miRNA (SEQ ID NO: 5) and 2 μL of 10 mg / mL prepared magnetic beads with capture probe (SEQ ID NO: 1) in 100 μL hybridization buffer, and incubated at 37°C for 30 minutes.

[0014] Further, in step (2), Step 2 separated the circRNA-miRNA complex by magnetic separation and washed 3 times with washing buffer to remove excess miRNA, followed by a rolling circle amplification (RCA) reaction, wherein the 50 μL reaction mixture contained: 3 μL of 3 μM circular DNA template, 4 μL of 10×Phi29 DNA polymerase reaction buffer, 5 μL of 10 mM dNTPs, 2 μL of 10×BSA, 1 μL of DEPC water and 1.5 μL of 1000 U / ml phi29 DNA polymerase, and then the mixture was incubated at 37°C for 40 minutes and heated at 70°C for 10 minutes to terminate the reaction.

[0015] Furthermore, in step (2), Step 3 adds the designed self-quenching molecular beacon probe (SEQ ID NO: 4), 100uM of 1.5uL of the self-quenching molecular beacon probe to the solution, and after incubation at room temperature for 30 minutes, it is dispensed into a 384-well plate and measured with a microplate reader for fluorescence intensity. The product is used for fluorescence microscopy imaging, and there is no need to terminate the reaction at high temperature, and it is directly magnetically separated and incubated directly with the fluorescent probe.

[0016] Furthermore, the nucleotide sequence of the primer Capture probe is as shown in the sequence listing SEQ ID NO: 1, the nucleotide sequence of the primer Imitated circMTO1 is as shown in the sequence listing SEQ ID NO: 2, the nucleotide sequence of the primer RCAtemplate is as shown in the sequence listing SEQ ID NO: 3, the nucleotide sequence of the primer Fluorescent probe is as shown in the sequence listing SEQ ID NO: 4, the nucleotide sequence of the primer miR-760 is as shown in the sequence listing SEQ ID NO: 5, the nucleotide sequence of the primer miR-218 is as shown in the sequence listing SEQ ID NO: 6, the nucleotide sequence of the primer miR-9 is as shown in the sequence listing SEQ ID NO: 7, the nucleotide sequence of the primer miR-484 is as shown in the sequence listing SEQ ID NO: 8, the nucleotide sequence of the primer miR-6764 is as shown in the sequence listing SEQ ID NO: 9, the nucleotide sequence of the primer miR-6824 is as shown in the sequence listing SEQ ID NO: 10, the nucleotide sequence of the primer Control miRNA is as shown in the sequence listing SEQ ID NO: 11, the primer 1 base mutation The nucleotide sequence of circMTO1 is shown in the sequence listing as SEQ ID NO: 12, the nucleotide sequence of the primer 3base mutation circMTO1 is shown in the sequence listing as SEQ ID NO: 13, the nucleotide sequence of the primer 1basemutation miR-760 is shown in the sequence listing as SEQ ID NO: 14, the nucleotide sequence of the primer 3base mutationmiR-760 is shown in the sequence listing as SEQ ID NO: 15, and the nucleotide sequence of the primer Artificial primer is shown in the sequence listing as SEQ ID NO: 16.

[0017] Beneficial effects: The assay method of the present invention has high sensitivity and can be used to analyze circRNA-miRNA interactions (cmRRI), which is expected to provide a useful tool for analyzing cmRRIs in RNA dialogue systems in biomedical and clinical inventions. Experiments have shown that only when sponge circRNA and adsorbed miRNA exist as a complex can the downstream RCA reaction be triggered and then a fluorescent signal is output.

[0018] Compared with the traditional methods, the present invention has the following advantages: (1) The present invention directly reveals the interaction between circRNA and miRNA, showing a significant advantage as a two-in-one integrated assay for cmRRI analysis without the need to detect circRNA and miRNA separately; (2) It produces quantitative results with high sensitivity, laying the foundation for subsequent in-depth functional inventions of circRNA. It can be further used to analyze the affinity of circRNA with candidate miRNA, broadening the scope of application of this method.

[0019] (3) The applications of cmRRI detection based on this method mainly include: a) experimental validation after bioinformatics analysis. b) replacing qRT-PCR when revealing signaling pathways mediated by circRNA and miRNA. Moreover, by simply replacing the capture recognition sequence of the probe, this method can also be applied to analyze the interaction between other competing endogenous RNAs and miRNAs. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 It is a schematic diagram of the magnetic separation operation of the present invention.

[0021] Figure 2 Schematic diagram of the method for analyzing circRNA-miRNA interaction (cmRRI) of the present invention.

[0022] Figure 3 The effect of the size of the streptavidin magnetic beads of the present invention on the construction of the biosensor. (A) Modification efficiency of the same concentration of capture probe (1 μL of 10 μM biotinylated capture probe and 100 μL of 10 mg / mL SA-MBs) on the surface of MBs with diameters of 0.3 μm, 1 μm, and 2 μm. (B) Fluorescence intensity response of MBs modified with capture probes in buffer (MBs diameter: 0.3 μm, 1 μm, and 2 μm) to 1 nM target. (C) Fluorescence imaging of MBs (MBs diameter: 0.3 μm, 1 μm, and 2 μm) with the addition of 1 nM target. The scale bar is 10 μm; the error value is the standard deviation of 3 independent experiments.

[0023] Figure 4 The zeta potential and agarose gel electrophoresis analysis of the present invention. (A) The zeta potentials indicated from left to right are: MB modified with DNA molecular probes; MB with captured circRNA / miRNA complexes; RCA reaction on the MB surface. (B) Agarose gel electrophoresis schematic diagram of RCA reaction, lane 1: miRNA, lane 2: linear template, lane 3: RCA template, lane 4: RCA product, lane 5: product without RCA reaction in the absence of miRNA.

[0024] Figure 5 Some optimization diagrams for detecting cmRRI method. Figure 5 A is a diagram showing the effect of the distance between the effective sequence region of the capture probe of the present invention and MB on the detection efficiency. Figure 5 B is the change of fluorescence intensity with RCA time in the present invention. The experiments were performed with 100 pM circRNA and 100 nM miRNA added to low-salt hybridization buffer. The error value is the standard deviation of 3 independent experiments.

[0025] Figure 6 It is a feasibility logic analysis diagram of the present invention. Figure 6 A is the truth table diagram of the "AND" logic gate of the present invention. Figure 6 B is a fluorescence response diagram of the biosensor of the present invention to circRNA, miRNA and circRNA / miRNA in buffer. Figure 6 C is the fluorescence intensity ratio (F / F0) of the control group and the experimental group of the present invention: (a) control, (b) in the presence of circRNA, (c) in the presence of miRNA, and (d) in the presence of circRNA / miRNA. Figure 6 D is the magnetic bead fluorescence imaging of miRNA, circRNA and circRNA / miRNA respectively input into the present invention. The scale bar is 10 μm; the error value is the standard deviation of 3 independent experiments.

[0026] Figure 7 It is a sensitivity analysis diagram of the sensor of the present invention. Figure 7 A is the fluorescence spectrum response of the present invention to various concentrations of circRNA in a low-salt hybridization buffer, where the miRNA concentration is 100 nM. Figure 7 B is the linear relationship between the fluorescence intensity and circRNA concentration of the present invention. The error value is the standard deviation of 3 independent experiments.

[0027] Figure 8 This is a specific analysis diagram of the sensor of the present invention. Figure 8 A is 12 cross combinations of three circRNAs (cM0, cM1 and cM3) and four miRNAs (mM0, mM1, mM3 and control) of the present invention. c refers to circRNA, m refers to miRNA, and M refers to mutation. Bottom: Selective response of the method to different combinations of mutant circRNA, mutant miRNA and control miRNA. Figure 8 B is a heat map of the present invention depicting the fluorescence intensity of 12 combinations of circRNA (10 nM) and miRNA (50 nM) (M represents base mutation). The error value is the standard deviation of 3 independent experiments.

[0028] Fig. 9 The figure shows the analysis of the affinity of different cmRRIs using the proposed method. Fig. 9 A is a schematic diagram of the binding affinity of the target circMTO1 of the present invention with different candidate miRNAs. Fig. 9 B is a trend diagram of the fluorescence intensity and maximum energy of circMTO1 of the present invention binding to miR-218, miR-9, miR-484, miR-760, miR-6764 and miR-6824, respectively. The error value is the standard deviation of three independent experiments. Fig. 9 C is the alignment of the complementary sequences of the six miRNAs with the sequences at the adsorption sites of circMTO1. The unit of maximum energy is Kcal / mol.

[0029] Fig.10 A is the fluorescence response diagram of circMTO1 / miRNA-760 of the present invention in buffer, 1% serum, 10% serum, 1% cell lysate and 10% cell lysate samples, respectively. The dilution solvent is a low-salt hybridization buffer. Fig.10 B is the target recovery rate in the five media of the present invention. The error value is the standard deviation of three independent experiments.

[0030] Fig.11 The interaction diagrams of circMTO1 / miRNA-9 and circMTO1 / miRNA-21 were detected in HCC tumor tissue and normal tissue, respectively. The patient numbers from left to right are: 1147868, 1145974, 1147666 and 1147852. The error value is the standard deviation of 3 independent experiments. DETAILED DESCRIPTION

[0031] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further described below in conjunction with specific implementation methods.

[0032] Example 1

[0033] The present invention discloses a two-in-one integrated assay for analyzing circRNA-microRNA interactions, comprising the following steps: (1) preparing functionalized magnetic beads (MBs): the capture probe is fixed on the surface of SA-MBs through the specific binding between biotin and streptavidin; step 1: wash 100 μL of 10 mg / mL SA-MBs twice with 1 mL of washing buffer, and then resuspend in 500 μL of biotin-streptavidin binding buffer. Step 2: add 2 μL of 100 μM biotinylated capture probe to the SA-MBs dispersion, and then incubate the mixture on a thermomixer at 37° C. for 30 minutes. Step 3: after washing 3 times with 1 mL of washing buffer to remove excess free probes, resuspend the capture probe MBs in 100 μL of hybridization buffer for subsequent experiments, and calculate the number of probes bound to the MBs: (concentration before reaction - concentration after reaction) × volume of reaction solution.

[0034] (2) circRNA-miRNA interaction analysis: After the functionalized MB separated the circRNA / miRNA complex, the rolling circle amplification (RCA) product using miRNA as primer opened the self-quenching probe to generate a fluorescent signal.

[0035] Step 1: Mix different concentrations of circRNA (SEQ ID NO: 2), 1 μM miRNA (SEQ ID NO: 5) and 2 μL of 10 mg / mL magnetic beads with capture probe (SEQ ID NO: 1) in 100 μL hybridization buffer and incubate at 37°C for 30 minutes.

[0036] Step 2: Separate the circRNA-miRNA complex by magnetic separation and wash three times with washing buffer to remove excess miRNA. Next, perform rolling circle amplification (RCA) reaction. The 50 μL reaction mixture contains: 3 μL of 3 μM circular DNA template, 4 μL of 10×Phi29 DNA polymerase reaction buffer, 5 μL of 10 mM dNTPs, 2 μL of 10×BSA, 1 μL of DEPC water and 1.5 μL of 1000 U / ml phi29 DNA polymerase. Then, incubate the mixture at 37°C for 40 min and heat at 70°C for 10 min to terminate the reaction.

[0037] Step 3: Add the designed self-quenching molecular beacon probe (SEQ ID NO: 4), 1.5uL of 100uM of the self-quenching molecular beacon probe to the solution, incubate at room temperature for 30 minutes, and then dispense into a 384-well plate to measure the fluorescence intensity on a microplate reader. The product is used for fluorescence microscopy imaging, and there is no need to terminate the reaction at high temperature, and it is directly magnetically separated and incubated directly with the fluorescent probe.

[0038] The nucleotide sequence of the primer Capture probe is as shown in the sequence listing SEQ ID NO: 1, the nucleotide sequence of the primer Imitated circMTO1 is as shown in the sequence listing SEQ ID NO: 2, the nucleotide sequence of the primer RCA template is as shown in the sequence listing SEQ ID NO: 3, the nucleotide sequence of the primer Fluorescent probe is as shown in the sequence listing SEQ ID NO: 4, the nucleotide sequence of the primer miR-760 is as shown in the sequence listing SEQ ID NO: 5, the nucleotide sequence of the primer miR-218 is as shown in the sequence listing SEQ ID NO: 6, the nucleotide sequence of the primer miR-9 is as shown in the sequence listing SEQ ID NO: 7, the nucleotide sequence of the primer miR-484 is as shown in the sequence listing SEQ ID NO: 8, the nucleotide sequence of the primer miR-6764 is as shown in the sequence listing SEQ ID NO: 9, the nucleotide sequence of the primer miR-6824 is as shown in the sequence listing SEQ ID NO: 10, the nucleotide sequence of the primer Control miRNA is as shown in the sequence listing SEQ ID NO: 11, the primer 1 basemutation The nucleotide sequence of circMTO1 is as shown in the sequence listing SEQ ID NO: 12, the nucleotide sequence of the primer 3base mutationcircMTO1 is as shown in the sequence listing SEQ ID NO: 13, the nucleotide sequence of the primer 1base mutation miR-760 is as shown in the sequence listing SEQ ID NO: 14, the nucleotide sequence of the primer 3base mutation miR-760 is as shown in the sequence listing SEQ ID NO: 15, and the nucleotide sequence of the primer Artificial primer is as shown in the sequence listing SEQ ID NO: 16.

[0039] Test Example 1

[0040] like Figure 1-3 As shown, the experimental part of the present invention

[0041] 1.1 Instrument

[0042] The reaction products were dispensed into black 384-well plates (Fluotrac 200, Greiner, Germany) and then placed in a fluorescence microplate reader (BioTek Instrument, Winooski, VT, USA) to measure the fluorescence emission spectrum of FAM dye at an excitation wavelength of 488 nm. Fluorescence imaging of magnetic beads (MBs) was observed under an IX73 fluorescence microscope (Olympus, Tokyo, Japan). HC-100 constant temperature mixer (Thermo, Shanghai, China) was used to mix the reaction reagents.

[0043] 1.2 Materials and reagents

[0044] Streptavidin-modified MBs (SA-MBs; 300 nm, 10 mg / mL) were purchased from Suzhou Beaver Biotechnology Co., Ltd. All oligonucleotide sequences used in the invention are listed in Table 1. The RNA sequence was synthesized by Takara Biotechnology Co., Ltd., and the DNA sequence was synthesized by Sangon Biotechnology Co., Ltd. and purified by HPLC. The buffer used in the present invention is as follows: the buffer used to bind biotin and streptavidin on magnetic beads is composed of 10 mM Tris-HCL, 1 mM EDTA, 1 M NaCl and 0.05% Tween-20 (pH: 7.4); the nucleic acid low-salt hybridization buffer is composed of 10 mM Tris-HCL, 1 mM EDTA and 150 mM NaCl (pH: 7.4); the washing buffer is composed of 10 mM Tris-HCL, 1 mM EDTA and 0.01% Tween-20 (pH: 7.4). All reagents used to prepare the buffer were purchased from Sigma-Aldrich Trading. The ultrapure water used in the present invention is produced by a Milli-Q instrument and has a resistivity of 18.2 MΩ·cm. All nucleic acid sequences used in the present invention are shown in Table 1:

[0045] Table 1

[0046]

[0047]

[0048] 1.3 Preparation of functionalized MB

[0049] The capture probes were immobilized on the surface of SA-MBs through the specific binding between biotin and streptavidin. First, 100 μL of 10 mg / mL SA-MBs were washed twice with 1 mL of wash buffer and then resuspended in 500 μL of biotin-streptavidin binding buffer. Subsequently, 2 μL of 100 μM biotinylated capture probes were added to the SA-MBs dispersion, and the mixture was incubated on a thermomixer at 37 °C for 30 min. Finally, after washing 3 times with 1 mL of wash buffer to remove excess free probes, the capture probe MBs were resuspended in 100 μL of hybridization buffer for subsequent experiments. Calculation of the number of probes bound to MBs: (concentration before reaction - concentration after reaction) × volume of reaction solution.

[0050] 1.4 circRNA-miRNA interaction analysis

[0051] First, different concentrations of circRNA, 1 μM miRNA and 2 μL of 10 mg / mL prepared magnetic beads with capture probes were mixed in 100 μL hybridization buffer and incubated at 37 °C for 30 min. Then, the circRNA-miRNA complex was separated by magnetism and washed three times with washing buffer to remove excess miRNA. Next, the rolling circle amplification (RCA) reaction was performed, and the 50 μL reaction mixture contained: 3 μL circular DNA template (3 μM), 4 μL 10×Phi29 DNA polymerase reaction buffer, 5 μL dNTPs (10 mM), 2 μL 10×BSA, 1 μL DEPC water and 1.5 μL phi29 DNA polymerase (1000 U / ml). Then, the mixture was incubated at 37 °C for 40 min and heated at 70 °C for 10 min to terminate the reaction. Finally, the designed self-quenching molecular beacon probe (1.5uL of 100uM) was added to the solution and incubated at room temperature for 30 minutes before being dispensed into a 384-well plate and the fluorescence intensity was measured by a microplate reader. If the product is used for fluorescence microscopy imaging, the step of terminating the reaction at high temperature is not required, and it is directly magnetically separated and incubated directly with the fluorescent probe. The specific steps of the operation are shown in the schematic diagram of the magnetic separation operation. Figure 1 shown.

[0052] Test Example 2

[0053] 1.5 Actual Sample Analysis

[0054] Hepatocellular carcinoma cell line (HepG2) was cultured in Dulbecco's modified Eagle's medium (DMEM) in a humidified box with 5% CO2 at 37°C. Among them, 100 μg / mL streptomycin and 10% fetal bovine serum were added to DMEM. After the cells grew to an appropriate density (about 80%), the cells were suspended in PBS buffer and then repeatedly frozen and thawed to obtain cell lysates for subsequent experiments. According to the regulations of the local ethics committee, whole blood from healthy people was obtained from the First Affiliated Hospital of Nanjing Medical University (Nanjing, China). After centrifugation at 3000 rpm, the serum on the upper layer of the test tube was collected for subsequent experiments.

[0055] In the present invention, spiking experiments were first performed to evaluate the potential of this method in actual biological samples, by spiking circRNA and miRNA standards into cell lysate and serum, detecting them using the proposed method, measuring the fluorescence intensity, converting it into concentration and comparing it with the added standards.

[0056] Liver cancer tissues were provided by the First Affiliated Hospital of Nanjing Medical University. This invention was approved by the Ethics Committee of Nanjing University and Nanjing Medical University. Total RNA in tissues was extracted using TRIzol reagent (Invitrogen, USA).

[0057] 1.6 Results and Discussion

[0058] 1.6.1 Sensor Design

[0059] Schematic diagram of the method used to analyze circRNA-miRNA interactions (cmRRI) Figure 2 As shown, Figure 2The principle of analyzing cmRRI in this work is briefly demonstrated. Since there are abundant circRNA homologues in biological samples, these molecules exist in the form of linear RNA. It is precisely because of the existence of these homologues that false positives are often observed when analyzing circRNA using the currently used methods without separation. Therefore, in order to accurately capture the circRNA / miRNA complex, the present invention first designs a DNA probe that can specifically recognize the reverse splicing junction site (BSJ) of the target circRNA. The sequence of the BSJ site is a conserved region of the circRNA, and a biotin molecule is modified at one end of the probe. Due to the interaction between the biotin molecule and the streptavidin on the magnetic beads, these DNA probes are successfully assembled on the magnetic beads. In the sample, when the target circRNA acts as a sponge for miRNA, it will adsorb the miRNA phase. At this time, the free part of the miRNA that is not completely bound to the circRNA will hybridize with the rolling circle amplification (RCA) in the solution, thereby acting as a primer for RCA and triggering the subsequent amplification reaction. The product of RCA is a large amount of long-chain DNA containing repeated fragments. At this time, a fluorescent signal is generated by adding a signal probe that is complementary to the tandem repeat sequence. All magnetic separation steps are performed before RCA to ensure that even if DNA falls off the surface of the magnetic beads after RCA, it will not affect the output of the signal. It is worth noting that a circRNA may contain multiple miRNA adsorption sites, and combined with the powerful and versatile RCA technology, the two can significantly enhance the signal.

[0060] Furthermore, this analysis can be logically used for the comprehensive analysis of cmRRI. As shown in Scheme 1, in the presence of a unique circRNA, the RCA reaction does not occur due to the lack of primers, while in the presence of only miRNA, the MB cannot capture the miRNA and the subsequent RCA reaction does not occur. Only in the presence of the circRNA / miRNA complex can RCA-assisted signal amplification be performed. In this way, the direct, sensitive, and specific analysis goals of cmRRI can be achieved, and quantitative information of the target circRNA can also be obtained during the analysis, providing a basis for subsequent work.

[0061] 1.6.2 Analysis of magnetic beads of different sizes as sensor elements

[0062] Figure 3Effect of the size of streptavidin beads on biosensor construction. (A) Modification efficiency of the same concentration of capture probe (1 μL of 10 μM biotinylated capture probe with 100 μL of 10 mg / mL SA-MBs) on the surface of MBs with diameters of 0.3 μm, 1 μm, and 2 μm. (B) Fluorescence intensity response of MBs (diameters of MBs: 0.3 μm, 1 μm, and 2 μm) modified with capture probes in buffer to 1 nM target. (C) Fluorescence imaging of MBs (diameters of MBs: 0.3 μm, 1 μm, and 2 μm) with the addition of 1 nM target. Scale bar is 10 μm; error value is the standard deviation of 3 independent experiments.

[0063] In order to achieve the best analysis effect, the present invention selected three different diameters of streptavidin magnetic beads (0.3 μm, 1 μm and 2 μm) and explored their effects on the detection effect of the biosensor. First, the DNA probe was co-incubated with the streptavidin-coated magnetic beads for 40 minutes under the same conditions. The remaining amount of probe in the test solution after magnetic separation was compared with the amount initially added, and the amount of probe bound to the magnetic beads was calculated. The results are shown in Figure 2. Figure 3 As shown in A, magnetic beads with a diameter of 0.3 μm have the largest loading capacity for DNA probes. Then, the present invention added the same concentration of circRNA / miRNA complexes to the three magnetic bead solutions, and tested the fluorescence signal intensity after the reaction was completed. The results showed that the magnetic beads with a diameter of 0.3 μm produced the strongest fluorescence signal ( Figure 3 B), which may be due to the smaller size of the magnetic beads adsorbing more DNA probes, thereby capturing more target complexes. The same conclusion was further verified under a fluorescence microscope ( Figure 3 C).

[0064] 1.6.3 Feasibility of sensor analysis cmRRI invention

[0065] Figure 4 .Zeta potential and agarose gel electrophoresis analysis. (A) The zeta potentials from left to right are: MB modified with DNA molecular probes; MB with captured circRNA / miRNA complexes; RCA reaction on the MB surface. (B) Schematic diagram of agarose gel electrophoresis of RCA reaction, lane 1: miRNA, lane 2: linear template, lane 3: RCA template, lane 4: RCA product, lane 5: product without RCA reaction in the absence of miRNA.

[0066] As a proof of concept, the present invention selects circMTO1 as a model circRNA. Abnormal expression of circMTO1 is a prognostic indicator of poor survival in patients with hepatocellular carcinoma (HCC). Zeta potential is the potential difference between the continuous phase and the fluid stable layer attached to the dispersed particles. It can be directly measured by electrokinetic phenomena. The present invention uses zeta testing to characterize the detection process of the sensor. Figure 4 As shown in A, after the magnetic beads modified with DNA probes captured the target complex, the surface potential changed negatively from -23mV to -38mV, which may be caused by the increase in the amount of nucleic acid caused by the hybridization of the capture probe and the target complex. After the RCA reaction occurred on the surface of the magnetic beads, the potential continued to shift negatively to -51mV, confirming the successful progress of the amplification reaction. At the same time, from the results of agarose gel electrophoresis ( Figure 4 B) It can be seen that lane 3 indicates the successful synthesis of the RCA circular template, lane 4 indicates that the rolling circle amplification reaction occurred, and lane 5 indicates that amplification cannot be performed in the absence of miRNA. The above results all prove that the RCA amplification reaction can occur when the target circRNA and miRNA coexist. Figure 5 (A) Effect of the distance between the effective sequence region of the capture probe and the MB on the detection efficiency. As shown in the schematic diagram, the intervals were designed to be 0, 16, 26, and 36 poly-T bases, respectively. (B) Fluorescence intensity changes with RCA time. The experiments were performed with 100 pM circRNA and 100 nM miRNA added to low-salt hybridization buffer. The error value is the standard deviation of 3 independent experiments.

[0067] The distance between the effective sequence region of the capture probe and the MB (called the linker) may affect the capture efficiency of the target and thus the intensity of the fluorescent signal. The present invention has compared four probes with different linker lengths, such as Figure 5 As shown in Figure A, a shorter linker resulted in a low fluorescence signal, which may be caused by the steric hindrance between the DNA probe and the MB. Therefore, the probe with a linker length of 26 bp that produced the maximum signal was selected in subsequent experiments. In addition, by testing the fluorescence at different RCA reaction times, it was found that the maximum fluorescence signal was obtained at about 65 minutes ( Figure 5 B). Figure 6Feasibility logic analysis. (A) Truth table of the AND logic gate. (B) Fluorescence response of the biosensor to circRNA, miRNA, and circRNA / miRNA in buffer. (C) Fluorescence intensity ratio (F / F0) of the control group and the experimental group: (a) control, (b) in the presence of circRNA, (c) in the presence of miRNA, and (d) in the presence of circRNA / miRNA. (D) Fluorescence imaging of magnetic beads input with miRNA, circRNA, and circRNA / miRNA, respectively. Scale bar is 10 μm; error value is the standard deviation of 3 independent experiments.

[0068] To verify the feasibility of the proposed sensor, the detection capability of the proposed method was first tested by logical analysis in a low-salt hybridization buffer. The capture probe was modified on streptavidin magnetic beads, such as Figure 6 As shown in Figure B, the fluorescence spectrum trends in the presence of only miRNA and only circRNA are almost the same as when no target is added, while when circRNA and miRNA coexist, the fluorescence spectrum has a higher peak. Analysis shows that the fluorescence intensity increases by 8.36 times when circRNA and miRNA coexist. Figure 6 C) In addition, if Figure 6 As shown in Figure D, the magnetic beads after the reaction under different input conditions were directly observed under a fluorescence microscope, and a trend consistent with the above results was obtained. These results show that only when the target circRNA and miRNA coexist, the assay will perform the "AND" logic gate operation and ultimately output a fluorescent signal. This is because the modified DNA probe on the magnetic beads can specifically capture the target circRNA, and the circRNA specifically adsorbs the miRNA. At this time, the miRNA acting as a primer can trigger the downstream RCA reaction, thereby generating a fluorescent response. Therefore, this method can directly detect cmRRI as a whole by analyzing the circRNA / miRNA complex instead of a single RNA.

[0069] 1.6.4 Sensor performance analysis

[0070] Figure 7 Sensitivity analysis of the sensor. (A) Fluorescence spectrum response to various concentrations of circRNA in low-salt hybridization buffer, when the miRNA concentration was 100 nM. (B) There is a linear relationship between fluorescence intensity and circRNA concentration. The error value is the standard deviation of 3 independent experiments.

[0071] After determining the feasibility of the method, the present invention further invented its analytical performance in terms of sensitivity and specificity. First, in order to explore the detection sensitivity of the method, circRNAs of different concentrations such as 0, 10 pM, 100 pM, 1 nM, 5 nM, 10 nM, and 50 nM were tested in the buffer. The results showed that with the increase of circRNA concentration, the fluorescence intensity gradually increased, and the curve fitting showed that the fluorescence intensity was proportional to the circRNA concentration, and the detection limit was close to 1.2 pM. The reason why the sensor can detect low-concentration targets may be: first, the surface of MBs is covered with high-density capture probes, which improves the efficiency of target molecule recognition; second, the RCA process effectively produces a large number of repetitive fragments that can hybridize with fluorescent probes.

[0072] Figure 8 Specificity analysis of the sensor. (A) Top: 12 cross-combinations of three circRNAs (cM0, cM1, and cM3) and four miRNAs (mM0, mM1, mM3, and control). c refers to circRNA, m refers to miRNA, and M refers to mutation. Bottom: Selective response of the method to different combinations of mutant circRNA, mutant miRNA, and control miRNA. (B) Heat map depicts the fluorescence intensity of 12 combinations of circRNA (10nM) and miRNA (50nM) (M indicates base mutation). The error value is the standard deviation of 3 independent experiments.

[0073] In order to test the specificity of this method for analyzing cmRRI, the present invention randomly mutated several bases of circRNA and miRNA binding sites, see Table 1. At the same time, interfering miRNA has been introduced as a control. Figure 8 As shown in A, a total of 12 combinations of three circRNAs and four miRNAs were cross-analyzed. The results show that the fluorescence intensity is the highest when neither the circRNA nor the miRNA has mutations. When there is a base mutation in the circRNA (no mutation in the miRNA), or a base mutation in the miRNA (no mutation in the circRNA), the fluorescence intensity drops by nearly 50%. When there are three base mutations, the fluorescence intensity is similar to that of the control group. Figure 8 B shows the specificity of the sensor more intuitively through a heat map, and the maximum fluorescence value is only produced when the circRNA and miRNA are perfectly paired. The above results indicate that the sensor can be used to analyze the effects of single base mutations in the interaction analysis between sponge circRNA and its corresponding miRNA.

[0074] 1.6.5 Analysis of sensor affinity for cmRRI

[0075] Fig. 9 (A) Schematic diagram of the binding affinity of target circMTO1 with different candidate miRNAs. (B) Trends of fluorescence intensity and maximum energy of circMTO1 binding to miR-218, miR-9, miR-484, miR-760, miR-6764 and miR-6824. The error value is the standard deviation of three independent experiments. (C) Complementary sequences of six miRNAs were aligned with the sequences at the adsorption sites of circMTO1. The unit of maximum energy is Kcal / mol.

[0076] Since circRNA usually acts as a sponge for miRNA with high affinity and indirectly regulates the expression of downstream target genes. It is worth noting that circRNA adsorbs miRNA through direct base complementary pairing. Therefore, circRNA / miRNA with strong base interactions have higher affinity. Therefore, an important application of cmRRI detection or cmRRI verification is to screen out miRNAs with higher affinity from candidate miRNAs predicted by bioinformatics that may interact with target circRNA for further downstream invention. Miranda software has predicted the target miRNA of circMTO1 (motif 250-260) and screened 6 miRNAs whose expression and function are related to HCC, including miR-218, miR-9, miR-484, miR-760, miR-6764 and miR-6824. Fig. 9 A and Fig. 9 As shown in Figure B, the fluorescence intensity generated by the interaction between each miRNA and circMTO1 is detected and compared with the maximum energy obtained by RNAfold prediction. The predicted maximum energy indicates the affinity of circMTO1 binding to the target miRNA. It is worth noting that since the hybridization reaction between circRNA and miRNA is an exothermic reaction, the maximum energy is negative, and the energy mentioned here refers to the absolute value. The trend between the fluorescence intensity and the predicted maximum energy is the same. MiRNAs with higher energy will produce high fluorescence signals, while miRNAs with lower energy will only be accompanied by lower fluorescence signals. The possible reason for this change in fluorescence intensity may be that the greater the energy, the higher the thermodynamic stability between circRNA and miRNA, and then circRNA will adsorb more miRNAs with strong affinity to it and be separated for subsequent amplification. miR-760, which has the highest output fluorescence signal, also has the most complementary bases to the circMTO1 binding site sequence ( Fig. 9C), which is consistent with the result predicted by circBase software that circMTO1 can act as a sponge for miR-760. Therefore, when several miRNAs that may interact with circRNA have been predicted by software, this method can be used to test affinity for final screening and validation.

[0077] 1.6.6 Detection application of sensors in biological samples; Fig.10 (A) Fluorescence responses of circMTO1 / miRNA-760 in buffer, 1% serum, 10% serum, 1% cell lysate, and 10% cell lysate samples. The dilution solvent was low-salt hybridization buffer. (B) Target recovery in the five media. The error value is the standard deviation of three independent experiments.

[0078] In traditional analytical methods, the analysis of cmRRI from some complex biological samples such as cell lysate and serum first requires the isolation and purification of total RNA, which is a complex and time-consuming process and is often accompanied by losses. In order to explore the practicality of this method in cell lysate and serum, hybridization buffer, 1% serum, 10% serum, 1% cell lysate and 10% cell lysate have been used as sample media for testing. 1nM and 10nM of circMTO1 were selected for combination testing with 100nM of miRNA-760, respectively. Fig.10 As can be seen in A, compared with the test results of hybridization buffer, the fluorescence signal response of circMTO1 / miRNA-760 complex in 1% serum, 10% serum, 1% cell lysate and 10% cell lysate showed negligible differences. The present invention further calculated the recovery rate of the target in these five media ( Fig.10 B), the recovery rate was 90%-102.9%, and the target recovery rate in complex biological samples was slightly different from that in buffer solution. The above results show that the biosensor can obtain similar detection effects in cell lysate and serum as in buffer solution. Fig.11 The interactions of circMTO1 / miRNA-9 and circMTO1 / miRNA-21 were detected in HCC tumor tissues and normal tissues, respectively. The patient numbers from left to right are: 1147868, 1145974, 1147666, and 1147852. The error value is the standard deviation of 3 independent experiments.

[0079] In order to further explore the practical application value of the sensor, in addition to testing in cell lysate and serum, the present invention also extracted total RNA from HCC tumor tissues and normal tissues, and then detected the interactions between circMTO1 / miRNA-9 and circMTO1 / miRNA-21 in these samples. Among them, it has been reported that miRNA-9 is involved in the development of HCC by interacting with circMTO1, and miRNA-21 is highly expressed in a variety of tumor tissues. As shown in Figure 11, the interaction between circMTO1 and miRNA-9 is very strong, while the interaction between circMTO1 and miRNA-21 is very weak, which is consistent with previous reports. The interaction force of circMTO1 / miRNA-9 in normal tissues is higher than that in tumor tissues, because the expression level of circMTO1 is reduced in liver cancer tissues. Combined with Fig.10 and Fig.11 The results showed that the method has good stability and accuracy under different biological conditions and target concentrations, indicating that the method may have clinical application value.

[0080] 1.7 Summary

[0081] The present invention proposes a method for analyzing circRNA-miRNA interaction (cmRRI). Experiments have shown that only when sponge circRNA and adsorbed miRNA exist as a complex can the downstream RCA reaction be triggered and then a fluorescent signal be output. Compared with traditional methods, this technology directly reveals the interaction between circRNA and miRNA, showing significant advantages: (1) It is a two-in-one integrated assay for cmRRI analysis without the need to detect circRNA and miRNA separately; (2) It produces quantitative results with high sensitivity, laying the foundation for subsequent in-depth functional inventions of circRNA. (3) It can be further used to analyze the affinity of circRNA with candidate miRNA, broadening the scope of application of this method. The application of cmRRI detection based on this method mainly includes: 1) Experimental verification after bioinformatics analysis. 2) Replacement of qRT-PCR when revealing signal pathways mediated by circRNA and miRNA. Moreover, by simply replacing the capture recognition sequence of the probe, this method can also be applied to analyze the interaction between other competing endogenous RNAs and miRNAs. Therefore, this method is expected to provide a useful tool for analyzing cmRRIs in RNA dialogue systems in biomedical and clinical inventions.

[0082] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents. Sequence Listing <110> Nanjing University <120> A two-in-one integrated assay for analyzing circRNA-microRNA interactions <130> 2020 <160> 16 <170> SIPOSequenceListing 1.0 <210> 1 <211> 18 <212> DNA <213> Artificial sequence (primer capture probe) <400> 1 acatctgacc caaaacaa 18 <210> 2 <211> 103 <212> DNA <213> Artificial sequence (primer Imitated circMTO1) <400> 2 gtcagatgtc atgtaatcct tcctttgagc tgtagaagat cttattctta gcaaccagag 60 cctgaacaca ctgggaaatg ccgtgtcagt ggggttgttt tgg 103 <210> 3 <211> 31 <212> DNA <213> Artificial sequence (primer RCA template) <400> 3 cagacaaccc gtccccacag acccaatccc c 31 <210> 4 <211> 25 <212> DNA <213> Artificial sequence (Fluorescent probe) <400> 4 ttttaacgtc cccacagact taaaa 25 <210> 5 <211> 20 <212> DNA <213> miR-760 <400> 5 cggctctggg tctgtgggga 20 <210> 6 <211> 22 <212> DNA <213> miR-218 <400> 6 cgcggtgctt gacagaacca tg 22 <210> 7 <211> 23 <212> DNA <213> miR-9 (miR-9) <400> 7 tcatacagct agataaccaa aga 23 <210> 8 <211> 22 <212> DNA <213> miR-484 <400> 8 atcgggaggg gactgagcct ga 22 <210> 9 <211> 21 <212> DNA <213> miR-6764 <400> 9 ctgtcaagga aagaccagag a 21 <210> 10 <211> 21 <212> DNA <213> miR-6824 <400> 10 ctggggtggc aagaccagag a 21 <210> 11 <211> twenty two <212> DNA <213> Artificial sequence (primer Control miRNA) <400> 11 tagcttatca gactgatgtt ga 22 <210> 12 <211> 103 <212> DNA <213> Artificial sequence (primer 1 base mutation circMTO1) <400> 12 gtcagatgtc atgtaatcct tcctttgagc tgtagaagat cttattctta gcaacgagag 60 cctgaacaca ctgggaaatg ccgtgtcagt ggggttgttt tgg 103 <210> 13 <211> 103 <212> DNA <213> Artificial sequence (primer 3 base mutation circMTO1) <400> 13 gtcagatgtc atgtaatcct tcctttgagc tgtagaagat cttattctta gcaacgagta 60 cctgaacaca ctgggaaatg ccgtgtcagt ggggttgttt tgg 103 <210> 14 <211> 20 <212> DNA <213> Artificial sequence (1 base mutation miR-760) <400> 14 cgactctggg tctgtgggga 20 <210> 15 <211> 20 <212> DNA <213> Artificial sequence (3 base mutation miR-760) <400> 15 cgaccgtggg tctgtgggga 20 <210> 16 <211> twenty one <212> DNA <213> Artificial primer <400> 16 taagatcttc gtctgtgggg a 21

Claims

1. A two-in-one integrated assay for analyzing circRNA-microRNA interactions, Features The method comprises the following steps: (1) preparing functionalized magnetic beads (MB): the capture probe is fixed on the surface of SA-MB through the specific binding between biotin and streptavidin; step 1 100 μL of 10 mg / mL streptavidin-modified magnetic beads (SA-MB) are washed twice with 1 mL of washing buffer and then resuspended in 500 μL of biotin-streptavidin binding buffer; (2) circRNA-miRNA interaction analysis: After the functionalized MB separated the circRNA / miRNA complex, the rolling circle amplification (RCA) product using miRNA as primer opened the self-quenching probe to generate a fluorescent signal; step 1: Mix different concentrations of circRNA, the nucleotide sequence of which is shown in SEQ ID NO: 2, 1 μM miRNA, the nucleotide sequence of which is shown in SEQ ID NO: 5, and 2 μL of 10 mg / mL prepared magnetic beads with capture probes, the nucleotide sequence of which is shown in SEQ ID NO: 1, in 100 μL hybridization buffer, and incubate at 37°C for 30 min.

2. The two-in-one integrated assay for analyzing circRNA-microRNA interactions according to claim 1, Features: In step (1), Step 2, 2 μL of 100 μM biotinylated capture probe was added to the SA-MBs dispersion, and the mixture was then incubated on a thermomixer at 37 °C for 30 min.

3. The two-in-one integrated assay for analyzing circRNA-microRNA interactions according to claim 1, Features: In step (1), after washing three times with 1 mL of washing buffer to remove excess free probes, the capture probe MBs were resuspended in 100 μL of hybridization buffer for subsequent experiments. The number of probes bound to the MBs was calculated as follows: (concentration before reaction - concentration after reaction) × volume of reaction solution.

4. The two-in-one integrated assay for analyzing circRNA-microRNA interactions according to claim 1, Features: In step (2), Step2 separated the circRNA-miRNA complex by magnetic separation and washed 3 times with washing buffer to remove excess miRNA, followed by rolling circle amplification (RCA) reaction. The 50 µL reaction mixture contained: 3 µL of 3 µM circular DNA template, 4 µL of 10×Phi29 DNA polymerase reaction buffer, 5 µL of 10 mM dNTPs, 2 µL10×BSA, 1 µL of DEPC water and 1.5 µL of 1000 U / ml of phi29 DNA polymerase. Then, the mixture was incubated at 37°C for 40 minutes and heated at 70°C for 10 minutes to terminate the reaction.

5. A two-in-one integrated assay for analyzing circRNA-microRNA interactions according to claim 4, Features: In step (2), Step 3 adds 1.5 uL of a 100 uM self-quenching molecular beacon probe designed to the solution, wherein the nucleotide sequence of the self-quenching molecular beacon probe is shown in SEQ ID NO: 4, and incubates at room temperature for 30 minutes before dispensing into a 384-well plate and measuring the fluorescence intensity on a microplate reader. The product is used for fluorescence microscopy imaging, and there is no need to terminate the reaction at high temperature, and it is directly magnetically separated and incubated directly with the fluorescent probe.